Cite

HARVARD Citation

    Su, G. et al. (2022). A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression. Clinical and translational medicine. 12 (2), p. n/a. [Online]. 
  
Back to record